Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bissler

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Orphanet Journal of Rare Diseases|May 2, 2019
A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus reportStéphane Auvin, John J Bissler, Vincent Cottin, et al.
Journal of Molecular Biology|February 19, 2003
Unpaired structures in SCA10 (ATTCT)n.(AGAAT)n repeatsVladimir N Potaman, John J Bissler, Vera I Hashem, et al.
The New England Journal of Medicine|January 11, 2008
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosisJohn J Bissler, Francis X McCormack, Lisa R Young, et al.
American Journal of Physiology. Renal Physiology|June 13, 2014
Evidence for pericyte origin of TSC-associated renal angiomyolipomas and implications for angiotensin receptor inhibition therapyBrian J Siroky, Hong Yin, Bradley P Dixon, et al.
Plos One|August 10, 2017
Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 studyJohn J Bissler, J Chris Kingswood, Elzbieta Radzikowska, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 10, 2015
Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trialJohn J Bissler, John Christopher Kingswood, Elżbieta Radzikowska, et al.
Physiological Reports|January 25, 2019
Tuberous sclerosis complex exhibits a new renal cystogenic mechanismJohn J Bissler, Fahad Zadjali, Dave Bridges, et al.
Chest|April 13, 2010
Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseasesLisa R Young, Rhonda Vandyke, Peter M Gulleman, et al.
Pediatric Neurology|June 9, 2016
Advances and Future Directions for Tuberous Sclerosis Complex Research: Recommendations From the 2015 Strategic Planning ConferenceMustafa Sahin, Elizabeth P Henske, Brendan D Manning, et al.
American Journal of Physiology. Renal Physiology|April 24, 2015
Hyperglycemia in the absence of cilia accelerates cystogenesis and induces renal damageKelli M Sas, Hong Yin, Wayne R Fitzgibbon, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Orphanet Journal of Rare Diseases|May 2, 2019
A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus reportStéphane Auvin, John J Bissler, Vincent Cottin, et al.
Journal of Molecular Biology|February 19, 2003
Unpaired structures in SCA10 (ATTCT)n.(AGAAT)n repeatsVladimir N Potaman, John J Bissler, Vera I Hashem, et al.
The New England Journal of Medicine|January 11, 2008
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosisJohn J Bissler, Francis X McCormack, Lisa R Young, et al.
American Journal of Physiology. Renal Physiology|June 13, 2014
Evidence for pericyte origin of TSC-associated renal angiomyolipomas and implications for angiotensin receptor inhibition therapyBrian J Siroky, Hong Yin, Bradley P Dixon, et al.
Plos One|August 10, 2017
Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 studyJohn J Bissler, J Chris Kingswood, Elzbieta Radzikowska, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 10, 2015
Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trialJohn J Bissler, John Christopher Kingswood, Elżbieta Radzikowska, et al.
Physiological Reports|January 25, 2019
Tuberous sclerosis complex exhibits a new renal cystogenic mechanismJohn J Bissler, Fahad Zadjali, Dave Bridges, et al.
Chest|April 13, 2010
Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseasesLisa R Young, Rhonda Vandyke, Peter M Gulleman, et al.
Pediatric Neurology|June 9, 2016
Advances and Future Directions for Tuberous Sclerosis Complex Research: Recommendations From the 2015 Strategic Planning ConferenceMustafa Sahin, Elizabeth P Henske, Brendan D Manning, et al.
American Journal of Physiology. Renal Physiology|April 24, 2015
Hyperglycemia in the absence of cilia accelerates cystogenesis and induces renal damageKelli M Sas, Hong Yin, Wayne R Fitzgibbon, et al.
Pageof 10